Clinical trial · Observational
Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis
Prospective Study on Elderly (≥ 65 Years) Patients Affected With Classical Hodgkin Lymphoma Undergoing Comprehensive Geriatric Assessment at Diagnosis
NCT03552003CI-TRIAL-00060571unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to develop a prognostic index for elderly patients with newly diagnosed cHL starting from a prospective observational study of consecutive cases registered after the completion of the Comprehensive Geriatric Assessment (CGA)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Classical Hodgkin Lymphoma | Classic Hodgkin Lymphoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Treatment for clinical practise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Newly diagnosed elderly cHL patients
- description
- Newly diagnosed elderly cHL patients undergoing CGA before any therapy (treatment for clinical practise) with the use of ADL, IADL and CIRS-G. Patients who will be considered not eligible to receive treatment or to be given only palliative therapy after CGA assessment are eligible for the study
- interventionNames
- Other: Treatment for clinical practise
Primary outcomes (1)
- measure
- OS
- timeFrame
- June 2018-December 2025 (7.5 years)
- description
- Overall survival (OS). From the date of diagnosis to the date of last observation or death from any cause
Secondary outcomes (3)
- measure
- PFS
- timeFrame
- June 2018-December 2025 (7.5 years)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. Diagnosis of classical Hodgkin Lymphoma 2. Age ≥ 65 year 3. Evaluation of Comprehensive Geriatric Assessment at baseline 4. Signed informed consent 5. Previously untreated patients Exclusion Criteria: None
References
Publications (0)
Data not yet available
No reference posted for this study.